Top

BMC Musculoskeletal Disorders

Published in:

01-12-2022 | Insulins | Research

Effects of continuous subcutaneous insulin infusion on the microstructures, mechanical properties and bone mineral compositions of lumbar spines in type 2 diabetic rats

Authors: Xiaorong Hu, He Gong, Aiqi Hou, Xiaodan Wu, Peipei Shi, Yingying Zhang

Published in: BMC Musculoskeletal Disorders | Issue 1/2022

Abstract

Background

Continuous subcutaneous insulin infusion (CSII) for the treatment of type 2 diabetes (T2D) can improve the structure and strength of femur of rats, but the effect of CSII treatment on the lumbar spine of T2D rats is unknown. The purpose of this study is to investigate the effects of CSII on the microstructure, multi-scale mechanical properties and bone mineral composition of the lumbar spine in T2D rats.

Methods

Seventy 6-week-old male Sprague–Dawley (SD) rats were divided into two batches, each including Control, T2D, CSII and Placebo groups, and the duration of insulin treatment was 4-week and 8-week, respectively. At the end of the experiment, the rats were sacrificed to take their lumbar spine. Microstructure, bone mineral composition and nanoscopic-mesoscopic-apparentand-macroscopic mechanical properties were evaluated through micro-computed tomography (micro-CT), Raman spectroscopy, nanoindentation test, nonlinear finite element analysis and compression test.

Results

It was found that 4 weeks later, T2D significantly decreased trabecular thickness (Tb.Th), nanoscopic-apparent and partial mesoscopic mechanical parameters of lumbar spine (P < 0.05), and significantly increased bone mineral composition parameters of cortical bone (P < 0.05). It was shown that CSII significantly improved nanoscopic-apparent mechanical parameters (P < 0.05). In addition, 8 weeks later, T2D significantly decreased bone mineral density (BMD), bone volume fraction (BV/TV) and macroscopic mechanical parameters (P < 0.05), and significantly increased bone mineral composition parameters of cancellous bone (P < 0.05). CSII treatment significantly improved partial mesoscopic-macroscopic mechanical parameters and some cortical bone mineral composition parameters (P < 0.05).

Conclusions

CSII treatment can significantly improve the nanoscopic-mesoscopic-apparent-macroscopic mechanical properties of the lumbar spine in T2D rats, as well as the bone structure and bone mineral composition of the lumbar vertebrae, but it will take longer treatment time to restore the normal level. In addition, T2D and CSII treatment affected bone mineral composition of cortical bone earlier than cancellous bone of lumbar spine in rat. Our study can provide evidence for clinical prevention and treatment of T2D-related bone diseases.

Malanda B, Burgaz C, Njenga E, Muga J, Acharya K, Gardete L, et al. Diabetes care and education training audit for primary care physicians – Results from IDF Diab-CET Kenya study needs assessment survey. Diabetes Res Clin Pract. 2020;159: 108012. https://doi.org/10.1016/j.diabres.2020.108012.CrossRefPubMed

Chen H, Jiang Y, Yang Z, Hu W, Xiong L, Wang N, et al. Effects of chimonanthus nitens oliv. leaf extract on glycolipid metabolism and antioxidant capacity in diabetic model mice. Oxid Med Cell Longev. 2017;2017:7648505. https://doi.org/10.1155/2017/7648505.CrossRefPubMedPubMedCentral

Qian W, Xu Z, Li F, Guan Q, Guan L, Li Q. Prevalence, awareness, treatment and control of diabetes mellitus among middle-aged and elderly people in a rural Chinese population: a cross-sectional study. PLoS ONE. 2018;13(6): e0198343. https://doi.org/10.1371/journal.pone.0198343.CrossRef

Gyawali B, Hansen MRH, Povlsen MB, Neupane D, Andersen PK, McLachlan CS, et al. Awareness, prevalence, treatment, and control of type 2 diabetes in a semi-urban area of Nepal: findings from a cross-sectional study conducted as a part of COBIN-D trial. PLoS ONE. 2018;13(11): e0206491. https://doi.org/10.1371/journal.pone.0206491.CrossRefPubMedPubMedCentral

Zhang YS, Weng WY, Xie BC, Meng Y, Hao YH, Liang YM, et al. Glucagon-like peptide-1 receptor agonists and fracture risk: a network meta-analysis of randomized clinical trials. Osteoporos Int. 2018;29(12):2639–44. https://doi.org/10.1007/s00198-018-4649-8.CrossRefPubMed

Leslie WD, Morin SN, Majumdaret SR, Lix LM. Effects of obesity and diabetes on rate of bone density loss. Osteoporos Int. 2018;29(1):61–7. https://doi.org/10.1007/s00198-017-4223-9.CrossRefPubMed

Komorita Y, Iwase M, Fujii H, Ohkuma T, Ide H, Jodai-Kitamura T, et al. Impact of body weight loss from maximum weight on fragility bone fractures in japanese patients with type 2 diabetes: the Fukuoka Diabetes Registry. Diabetes Care. 2018;41(5):1061–7. https://doi.org/10.2337/dc17-2004.CrossRefPubMed

Ho-Pham LT, Chau P, Do AT, Nguyen HC, Nguyen TV. Type 2 diabetes is associated with higher trabecular bone density but lower cortical bone density: the Vietnam Osteoporosis Study. Osteoporos Int. 2018;29(9):2059–67. https://doi.org/10.1007/s00198-018-4579-5.CrossRefPubMed

Saito M, Kida Y, Kato S, Marumo K. Diabetes, Collagen, and Bone Quality. Curr Osteoporos Rep. 2014;12(2):181–8. https://doi.org/10.1007/s11914-014-0202-7.CrossRefPubMed

10.

Acevedo C, Sylvia M, Schaible E, Graham JL, Stanhope KL, Metz LN, et al. Contributions of Material Properties and Structure to Increased Bone Fragility for a Given Bone Mass in the UCD-T2DM Rat Model of Type 2 Diabetes. J Bone Miner Res. 2018;33(6):1066–75. https://doi.org/10.1002/jbmr.3393.CrossRefPubMed

11.

Rokidi S, Andrade VFC, Borba V, Shane E, Cohen A, Zwerina J, et al. Bone tissue material composition is compromised in premenopausal women with Type 2 diabetes. Bone. 2020;141: 115634. https://doi.org/10.1016/j.bone.2020.115634.CrossRefPubMed

12.

Carbone S, Dixon DL, Buckley LF, Abbate A. Glucose-lowering therapies for cardiovascular risk reduction in type 2 diabetes mellitus: state-of-the-art review. Mayo Clin Proc. 2018;93(11):1629–47. https://doi.org/10.1016/j.mayocp.2018.07.018.CrossRefPubMed

13.

Hsieh YT, Tsai MJ, Tu ST, Hsieh MC. Association of abnormal renal profiles and proliferative diabetic retinopathy and diabetic macular edema in an asian population with type 2 diabetes. Jama Ophthalmol. 2018;136(1):68–74. https://doi.org/10.1001/jamaophthalmol.2017.5202.CrossRefPubMed

14.

Hunt HB, Torres AM, Palomino PM, Marty E, Saiyed R, Cohn M, et al. Altered tissue composition, microarchitecture, and mechanical performance in cancellous bone from men with type 2 diabetes mellitus. J Bone Miner Res. 2019;34(7):1191–206. https://doi.org/10.1002/jbmr.3711.CrossRefPubMed

15.

Kong D, Shi Y, Lin G, Jiang B, Du J. Recent advance in evaluation methods for characterizing mechanical properties of bone. Arch Comput Methods Eng. 2020;27:711–23. https://doi.org/10.1007/s11831-019-09322-2.CrossRef

16.

Lebovitz HE. Thiazolidinediones: the forgotten diabetes medications. Curr Diab Rep. 2019;19(12):151. https://doi.org/10.1007/s11892-019-1270-y.CrossRefPubMedPubMedCentral

17.

Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a positions statement of the American diabetes association and the European association for the study of diabetes. Diabetes Care. 2015;38(1):140–9. https://doi.org/10.2337/dc14-2441.CrossRefPubMed

18.

Hygum K, Harsløf T, Jørgensen NR, Rungby J, Pedersen SB, Langdahl BL. Bone resorption is unchanged by liraglutide in type 2 diabetes patients: A randomised controlled trial. Bone. 2020;132: 115197. https://doi.org/10.1016/j.bone.2019.115197.CrossRefPubMed

19.

Stage TB, Christensen MH, Jørgensen NR, Beck-Nielsen H, Brøsen K, Gram J, et al. Effects of metformin, rosiglitazone and insulin on bone meabolism in patients with type 2 diabetes. Bone. 2018;112:35–41. https://doi.org/10.1016/j.bone.2018.04.004.CrossRefPubMed

20.

Ruppert K, Cauley J, Lian Y, Zgibor JC, Derby C, Solomon DH. The effect of insulin on bone mineral density among women with type 2 diabetes: a SWAN Pharmacoepidemiology study. Osteoporosis Int. 2018;29(2):347–54. https://doi.org/10.1007/s00198-017-4276-9.CrossRef

21.

Cabré C, Colungo C, Vinagre I, Jansà M, Conget I. Frequency and awareness of hypoglycemia in patients with Type 2 Diabetes treated with two or more insulin injections in primary care outpatient clinics. Prim Care Diabetes. 2020;14(2):168–72. https://doi.org/10.1016/j.pcd.2019.08.001.CrossRefPubMed

22.

Reznik Y. Continuous subcutaneous insulin infusion (CSII) using an external insulin pump for the treatment of type 2 diabetes. Diabetes Metab. 2010;36(6 Pt 1):415–21. https://doi.org/10.1111/dom.13947.CrossRefPubMed

23.

Pickup JC. Diabetes: insulin pump therapy for type 2 diabetes mellitus. Nat Rev Endocrinol. 2014;10(11):647–9. https://doi.org/10.1038/nrendo.2014.142.CrossRefPubMed

24.

Grunberger G, Bhargava A, Ly T, Zisser H, Ilag LL, Malone J, et al. Human regular U-500 insulin via continuous subcutaneous insulin infusion versus multiple daily injections in adults with type 2 diabetes: The VIVID study. Diabetes Obes Metab. 2020;22(3):434–41. https://doi.org/10.1111/dom.13947.CrossRefPubMedPubMedCentral

25.

Nyman JS, Kalaitzoglou E, Clay Bunn R, Uppuganti S, Thrailkill KM, Fowlkes JL. Preserving and restoring bone with continuous insulin infusion therapy in a mouse model of type 1 diabetes. Bone Rep. 2017;7:1–8. https://doi.org/10.1016/j.bonr.2017.07.001.CrossRefPubMedPubMedCentral

26.

Shi P, Hou A, Li C, Wu X, Jia S, Cen H, et al. Continuous subcutaneous insulin infusion ameliorates bone structures and mechanical properties in type 2 diabetic rats by regulating bone remodeling. Bone. 2021;153: 116101. https://doi.org/10.1016/j.bone.2021.116101.CrossRefPubMed

27.

Otani T, Mano I, Tsujimoto T, Yamamoto T, Teshima R, Naka H. Estimation of in vivo cancellous bone elasticity. J Acoust Soc of Am. 2008;123(5):3632. https://doi.org/10.1121/1.2934872.CrossRef

28.

Broz K, Walk RE, Tang SY. Complications in the spine associated with type 2 diabetes: The role of advanced glycation end-products. MEDNTD. 2021;11(1): 100065. https://doi.org/10.1016/j.medntd.2021.100065.CrossRef

29.

Miyake H, Kanazawa I, Sugimoto T. Association of bone mineral density, bone turnover markers, and vertebral fractures with all-cause mortality in type 2 diabetes mellitus. Calcif Tissue Int. 2018;102(1):1–13. https://doi.org/10.1007/s00223-017-0324-x.CrossRefPubMed

30.

Guo XX, Wang Y, Wang K, Ji BP, Zhou F. Stability of a type 2 diabetes rat model induced by high-fat diet feeding with low-dose streptozotocin injection. J Zhejiang Univ Sci B. 2018;19(7):559–69. https://doi.org/10.1631/jzus.b1700254.CrossRefPubMedPubMedCentral

31.

Rho JY, Tsui TY, Pharr GM. Elastic properties of human cortical and trabecular lamellar bone measured by nanoindentation. Biomaterials. 1997;18(20):1325–30. https://doi.org/10.1016/s0142-9612(97)00073-2.CrossRefPubMed

32.

Oliver WC, Pharr GM. An improved technique for determining hardness and elastic modulus using load and displacement sensing indentation experiments. J Mater Res. 1992;7:1564–83. https://doi.org/10.1557/JMR.1992.1564.CrossRef

33.

Hammond MA, Gallant MA, Burr DB, Wallace JM. Nanoscale changes in collagen are reflected in physical and mechanical properties of bone at the microscale in diabetic rats. Bone. 2014;60:26–32. https://doi.org/10.1016/j.bone.2013.11.015.CrossRefPubMed

34.

Kochetkova T, Peruzzi C, Braun O, Overbeck J, Maurya AK, Neels A, et al. Combining polarized Raman spectroscopy and micropillar compression to study microscale structure-property relationships in mineralized tissues. Acta Biomater. 2021;119:390–404. https://doi.org/10.1016/j.actbio.2020.10.034.CrossRefPubMed

35.

Dragomir-Daescu D, Salas C, Uthamaraj S, Rossman T. Quantitative computed tomography-based finite element analysis predictions of femoral strength and stiffness depend on computed tomography settings. J Biomech. 2015;48(1):153–61. https://doi.org/10.1016/j.jbiomech.2014.09.016.CrossRefPubMed

36.

Giambini H, Wang HJ, Zhao C, Chen Q, Nassr A, An KN. Anterior and posterior variations in mechanical properties of human vertebrae measured by nanoindentation. J Biomech. 2013;46(3):456–61. https://doi.org/10.1016/j.jbiomech.2012.11.008.CrossRefPubMed

37.

Xu M, Yang J, Lieberman IH, Haddas R. Lumbar spine finite element model for healthy subjects: development and validation. Comput Methods Biomech Biomed Engin. 2016;20(1):1–15. https://doi.org/10.1080/10255842.2016.1193596.CrossRefPubMed

38.

Gong H, Zhang M, Fan Y. Micro-finite element analysis of trabecular bone yield behavior effects of tissue non-linear material properties. J Mech Med Biol. 2011;11(3):563–80. https://doi.org/10.1142/S0219519411004010.CrossRef

39.

Zhou LQ, Yang B. Simulation of a hot-rolled h-section steel beam subject to static loading based on discrete element method. Procedia Eng. 2017;210:312–9. https://doi.org/10.1016/j.proeng.2017.11.082.CrossRef

40.

Ma R, Wang L, Zhao B, Liu C, Liu H, Zhu R, et al. Diabetes perturbs bone microarchitecture and bone strength through regulation of sema3a/igf-1/β-catenin in rats. Cell Physiol Biochem. 2017;41(1):55–66. https://doi.org/10.1159/000455936.CrossRefPubMed

41.

Hua Y, Bi R, Zhang Y, Xu L, Guo J, Li Y. Different bone sites-specific response to diabetes rat models: Bone density, histology and microarchitecture. PLoS ONE. 2018;13(10): e0205503. https://doi.org/10.1371/journal.pone.0205503.CrossRefPubMedPubMedCentral

42.

Schwartz AV. Diabetes mellitus: does it affect bone? Calcif Tissue Int. 2003;73(6):515–9. https://doi.org/10.1007/s00223-003-0023-7.CrossRefPubMed

43.

Abdulameer SA, Sulaiman SA, Hassali MA, Subramaniam K, Sahib MN. Osteoporosis and type 2 diabetes mellitus: What do we know, and what we can do? Patient prefer adherence. 2012;6:435–48. https://doi.org/10.2147/ppa.s32745.CrossRefPubMedPubMedCentral

44.

American Diabetes Association. Standards of medical care in diabetes—2019 abridged for primary care providers. Clin Diabetes. 2019;37(1):11–34. https://doi.org/10.2337/cd18-0105.CrossRefPubMedCentral

45.

Wilson SJ, Christensen AM. A test of the citrate method of PMI estimation from skeletal remains. Forensic Sci Int. 2017;270:70–5. https://doi.org/10.1016/j.forsciint.2016.11.026.CrossRefPubMed

46.

Chen H, Wang Y, Dai H, Tian X, Cui ZK, Chen Z, et al. Bone and plasma citrate is reduced in osteoporosis. Bone. 2018;114:189–97. https://doi.org/10.1016/j.bone.2018.06.014.CrossRefPubMed

47.

Schneiders W, Reinstorf A, Pompe W, Grass R, Biewener A, Holch M, et al. Effect of modification of hydroxyapatite/collagen composites with sodium citrate, phosphoserine, phosphoserine/RGD-peptide and calcium carbonate on bone remodelling. Bone. 2007;40(4):1048–59. https://doi.org/10.1016/j.bone.2006.11.019.CrossRefPubMed

48.

Erdal N, Gürgül S, Kavak S, Yildiz A, Emre M. Deterioration of Bone Quality by Streptozotocin (STZ)-Induced Type 2 Diabetes Mellitus in Rats. Biol Trace Elem Res. 2011;140(3):342–53. https://doi.org/10.1007/s12011-010-8703-4.CrossRefPubMed

49.

Gürgül S, Erdal N, Yilmaz SN, Yildiz A, Ankarali H. Deterioration of bone quality by long-term magnetic field with extremely low frequency in rats. Bone. 2008;42(1):74–80. https://doi.org/10.1016/j.bone.2007.08.040.CrossRefPubMed

50.

Burr DB. The contribution of the organic matrix to bone’s material properties. Bone. 2002;31(1):8–11. https://doi.org/10.1016/s8756-3282(02)00815-3.CrossRefPubMed

51.

Turner CH. Biomechanics of bone: determinants of skeletal fragility and bone quality. Osteoporos Int. 2002;13(2):97–104. https://doi.org/10.1007/s001980200000.CrossRefPubMed

52.

Peng Z, Tuukkanen J, Zhang H, Jämsä T, Väänänen HK. The mechanical strength of bone in different rat models of experimental osteoporosis. Bone. 1994;15(5):523–32. https://doi.org/10.1016/8756-3282(94)90276-3.CrossRefPubMed

53.

Boyar H, Turan B, Severcan F. FTIR spectroscopic investigation of mineral structure of streptozotocin induced diabetic rat femur and tibia. Spectroscopy. 2003;17:627–33. https://doi.org/10.1155/2003/826545.CrossRef

54.

Sihota P, Yadav RN, Dhaliwal R, Bose JC, Dhiman V, Neradi D, et al. Investigation of mechanical, material and compositional determinants of human trabecular bone quality in type 2 diabetes. J Clin Endocrinol Metab. 2021;106(5):e2271–89. https://doi.org/10.1210/clinem/dgab027.CrossRefPubMed

55.

Goodyear SR, Gibson IR, Skakle JM, Wells RP, Aspden RM. A comparison of cortical and trabecular bone from C57 black 6 mice using Raman spectroscopy. Bone. 2009;44(5):899–907. https://doi.org/10.1016/j.bone.2009.01.008.CrossRefPubMed

56.

Jee W, Yao W. Overview: animal models of osteopenia and osteoporosis. J Musculoskelet Neuronal Interact. 2001;1(3):193–207.PubMed

57.

de Souza RA, Xavier M, da Silva FF, de Souza MT, Tosato MG, Martin AA, et al. Influence of creatine supplementation on bone quality in the ovariectomized rat model: an FT-Raman spectroscopy study. Lasers Med Sci. 2012;27(2):487–95. https://doi.org/10.1007/s10103-011-0976-0.CrossRefPubMed

58.

Gong H, Wang L, Fan Y, Zhang M, Qin L. Apparent- and tissue-level yield behaviors of l4 vertebral trabecular bone and their associations with microarchitectures. Ann Biomed Eng. 2015;44(4):1204–23. https://doi.org/10.1007/s10439-015-1368-6.CrossRefPubMed

59.

Yadav RN, Sihota P, Uniyal P, Neradi D, Bose JC, Dhiman V, et al. Prediction of mechanical properties of trabecular bone in patients with type 2 diabetes using damage based finite element method. J Biomech. 2021;123: 110495. https://doi.org/10.1016/j.jbiomech.2021.110495.CrossRefPubMed

60.

Hu Z, Ma C, Liang Y, Zou S, Liu X. Osteoclasts in bone regeneration under type 2 diabetes mellitus. Acta Biomater. 2019;84:402–13. https://doi.org/10.1016/j.actbio.2018.11.052.CrossRefPubMed

61.

Li Y, Tseng WJ, de Bakker CMJ, Zhao H, Chung R, Liu XS. Peak trabecular bone microstructure predicts rate of estrogen-deficiency-induced bone loss in rats. Bone. 2021;145: 115862. https://doi.org/10.1016/j.bone.2021.115862.CrossRefPubMedPubMedCentral

Title: Effects of continuous subcutaneous insulin infusion on the microstructures, mechanical properties and bone mineral compositions of lumbar spines in type 2 diabetic rats
Authors: Xiaorong Hu
He Gong
Aiqi Hou
Xiaodan Wu
Peipei Shi
Yingying Zhang
Publication date: 01-12-2022
Publisher: BioMed Central
Keywords: Insulins
Insulins
Type 2 Diabetes
Published in: BMC Musculoskeletal Disorders / Issue 1/2022
Electronic ISSN: 1471-2474
DOI: https://doi.org/10.1186/s12891-022-05452-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Effects of continuous subcutaneous insulin infusion on the microstructures, mechanical properties and bone mineral compositions of lumbar spines in type 2 diabetic rats

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2022

Smartphones for musculoskeletal research – hype or hope? Lessons from a decennium of mHealth studies

Effects of a 1-mm difference in bearing thickness on intraoperative bearing movement and kinematics in Oxford unicompartmental knee arthroplasty

High levels of TDO2 in relation to pro-inflammatory cytokines in synovium and synovial fluid of patients with osteoarthritis

Evaluation of double-high insert mid-term outcomes in cruciate-retaining medial-pivotal total knee arthroplasty – a propensity score-matched analysis with averaged 8-year follow-up

Obesity and perioperative adverse events in patients undergoing complex revision surgery for the thoracolumbar spine

Effect of verapamil on bone mass, microstructure and mechanical properties in type 2 diabetes mellitus rats